Dr. Miriam Pomeranz, MD

  • New York, NY
  • Dermatologist
NPI1457340499PAC ID4688858376
Medicare services, 2024
374
Medicare patients, 2024
225
Part D claims, 2024
709
Publications
69
MIPS score, 2024
91
Practice address
462 First Avenue, New York, NY 10016
Practice phone
Call (212) 561-4132
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

NYC Health + Hospitals/Bellevue

Hospital · New York, New York

See all 4 affiliations

Find Dr. Pomeranz's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Miriam Pomeranz is a dermatologist in New York, New York

Dr. Pomeranz practices at NYC Health + Hospitals/Bellevue in New York, New York, part of NYC.

Dr. Pomeranz's NPI, 1457340499, was assigned on October 20, 2005. Dr. Pomeranz graduated from Perelman School of Medicine at the University of Pennsylvania in 1989. Dr. Pomeranz holds New York license 182794.

NPI and contact details
Medicare PAC ID
4688858376
NPI enumeration date
October 20, 2005
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(212) 561-4132
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
63
Medical school graduation
1989

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Miriam Pomeranz practices at NYC Health + Hospitals/Bellevue in New York, New York

Dr. Pomeranz's primary practice is NYC Health + Hospitals/Bellevue, at 462 First Avenue, New York, NY 10016 in New York County. The practice phone is (212) 561-4132.

Source: Dmand AI Affiliation Data

Dr. Miriam Pomeranz is affiliated with 3 sites of care and 1 medical group

Dr. Pomeranz's primary practice is NYC Health + Hospitals/Bellevue in New York, New York, part of NYC. Dr. Pomeranz is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Pomeranz to 1 more group practice or clinic, named with a free account.

See all 4 affiliations for Dr. Pomeranz

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Miriam Pomeranz's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pomeranz practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
NYC Health + Hospitals/BellevueAvailable with a free account
+2 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Pomeranz practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across NYC and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Miriam Pomeranz is one of 1,038 dermatologists in New York

Dermatology is Dr. Pomeranz's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Pomeranz is licensed in New York.

Specialties and state licenses

  • Dermatology, New YorkPrimaryLicense 182794 · taxonomy 207N00000X

Dermatologists near Dr. Pomeranz

Counts of dermatologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Miriam Pomeranz billed Medicare for 374 services in 2024

CMS data shows 374 Medicare services from Dr. Pomeranz across 7 procedure codes in 2024, for 225 Medicare patients. Medicare paid $31,243 for them. Every service was in an office.

Medicare services, 2024374
Medicare patients225
Paid by Medicare$31,243
Procedure codes7

Dr. Pomeranz's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 2982024: 33813%
Surgery
2023: 342024: 366%

Dr. Pomeranz compared with the New York median for dermatologists, 2024

  • Dr. Pomeranz
  • New York median
Medicare services
374vs 1,01663% below
Medicare patients
225vs 32431% below
Part D claims
623vs 33487% above

Medians across 1,022 dermatologists in New York with Dmand AI profiles that report each measure.

Dr. Pomeranz's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Pomeranz

Need commercial claims for Dr. Pomeranz?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Pomeranz and other dermatologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Miriam Pomeranz treated 225 Medicare patients in 2024, average age 75

CMS counts 225 Medicare patients who saw Dr. Pomeranz in 2024. The largest group is 75 to 84, with 95 patients. 75% of them have high cholesterol, and 61% have arthritis. 8% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pomeranz's median patient age at 64, with 75% women.

Medicare patients, 2024225
Average age75
Average risk score0.98
Also on Medicaid8%

Dr. Pomeranz's Medicare patients by age, 2024

Dr. Pomeranz's Medicare patients by sex, 2024

  • Women21395%
  • Men125%

Chronic conditions among Dr. Pomeranz's Medicare patients, 2024

  1. High cholesterol75%
  2. Arthritis61%
  3. High blood pressure53%
  4. Osteoporosis41%
  5. Anxiety27%
  6. Ischemic heart disease27%
  7. Diabetes21%
  8. Mood disorders21%

Share of Medicare patients with each condition. A patient can have several.

Dr. Pomeranz's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 64

Patient panel by sex, all payers

  • Women75%
  • Men22%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Miriam Pomeranz wrote 709 Medicare Part D claims in 2024

In 2024, Dr. Pomeranz wrote 709 Medicare Part D claims for 194 patients. 91% of them were for generic drugs. CMS names the drug for 623 of them, across 18 drugs with 11 or more claims each, at $49,309 in total drug cost. In 2023, CMS named 535 claims across 16 drugs.

Part D claims, 2024709
Drugs named by CMS18
Total drug cost$49,309
Part D patients194

Dr. Pomeranz's Part D claims by kind of drug, 2024

  • Generic645 claims91%
  • Brand-name64 claims9%

Dr. Pomeranz's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 5352024: 62316%

Drugs named by CMS: 18 in 2024, 16 in 2023.

See all prescribing by Dr. Pomeranz

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Miriam Pomeranz scored 91 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Pomeranz for performance year 2024, reported as part of a group. Dr. Pomeranz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 25 procedures of removal of skin lesions by Dr. Pomeranz, more than 67% of the clinicians it reports for that procedure.

Accepts Medicare assignment
Yes

Dr. Pomeranz's MIPS scores, performance year 2024

  • 91of 100Final score
  • 91.8of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 75of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Where Dr. Pomeranz ranks in Medicare procedure volume

Removal of skin lesions
67th percentile25 procedures
Skin biopsy
60th percentile13 procedures

CMS ranks each clinician against every clinician it reports for the same procedure category.

Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find dermatologists like Dr. Pomeranz by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Miriam Pomeranz has 69 publications on record

Dmand AI links 69 papers to Dr. Pomeranz, published from 2011 to 2025. 2016 was the busiest year, with 9. The most frequent topics are Skin Neoplasms, Skin Diseases and Diagnosis, Differential. Dr. Pomeranz has published most often in Dermatol Online J. Dr. Pomeranz's most frequent co-authors are Randie H. Kim, MD, PhD, Kathryn Joyce Martires, MD and Alisa Nicole Femia, MD.

Papers69
Years published2011 to 2025

Dr. Pomeranz's papers by year, 2015 to 2025

Topics Dr. Pomeranz writes about most

  • Skin Neoplasms
  • Skin Diseases
  • Diagnosis, Differential
  • Pregnancy Complications
  • Vulvar Diseases
  • Melanoma
  • Biopsy
  • Cholestasis, Intrahepatic

Dr. Pomeranz's most frequent co-authors

Recent publications by Dr. Pomeranz

See all 69 publications and co-authors

See who Dr. Pomeranz researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Pomeranz works with, so you can find a warm path to the right dermatologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Miriam Pomeranz received $284 in industry payments from 2018 to 2025

CMS Open Payments shows 6 general payments to Dr. Pomeranz from 4 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 65% of the total. Janssen Pharmaceuticals, Inc paid the most, $100.

General payments to Dr. Pomeranz by program year, 2018 to 2025

General payments to Dr. Pomeranz by kind, 2018 to 2025

$284in total
  • Food and beverage$18465%
  • Education$10035%

Companies that paid Dr. Pomeranz the most, 2018 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Pomeranz

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Miriam Pomeranz graduated from Perelman School of Medicine at the University of Pennsylvania

Dr. Pomeranz graduated from Perelman School of Medicine at the University of Pennsylvania in 1989.

  1. Medical schoolPerelman School of Medicine at the University of Pennsylvania

Source: Dmand AI Professional Profile Data

Sources for Dr. Miriam Pomeranz's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Miriam Pomeranz

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Miriam Pomeranz's NPI number?

Dr. Miriam Pomeranz's NPI number is 1457340499. It was assigned on October 20, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Miriam Pomeranz?

Dr. Miriam Pomeranz is a dermatologist in New York, New York. The primary specialty in the NPI Registry is Dermatology Physician (taxonomy code 207N00000X).

Where does Dr. Miriam Pomeranz practice?

Dr. Pomeranz practices at 462 First Avenue, New York, NY 10016. Dr. Pomeranz's primary practice is NYC Health + Hospitals/Bellevue in New York, New York, part of NYC. Dmand AI also links Dr. Pomeranz to 1 group practice or clinic.

What is Dr. Miriam Pomeranz's office phone number?

The practice phone on file for Dr. Pomeranz is (212) 561-4132.

What is Dr. Miriam Pomeranz's medical license number?

Dr. Pomeranz holds New York license 182794.

Which hospitals is Dr. Miriam Pomeranz affiliated with?

Dr. Pomeranz practices at NYC Health + Hospitals/Bellevue in New York, New York. Dr. Pomeranz is also affiliated with Tisch Hospital.

What medical group is Dr. Miriam Pomeranz part of?

Dr. Pomeranz is linked to NYU Langone Orthopedic Surgery Associates.

Does Dr. Miriam Pomeranz accept Medicare?

Yes. CMS data shows Dr. Pomeranz billed Medicare for 374 services in 2024, and Dr. Pomeranz accepts Medicare assignment.

What is Dr. Miriam Pomeranz's MIPS score?

Dr. Pomeranz's MIPS final score for performance year 2024 is 91 out of 100, reported as part of a group.

How many Medicare patients does Dr. Miriam Pomeranz see?

CMS counts 225 Medicare patients who saw Dr. Pomeranz in 2024, with an average age of 75.

Show 7 more questionsShow fewer questions

What services does Dr. Miriam Pomeranz bill to Medicare?

In 2024, Dr. Pomeranz's most billed Medicare services were office visit, established patient (99213), office visit, established patient (99214) and office visit, new patient (99203).

Where did Dr. Miriam Pomeranz go to medical school?

Dr. Pomeranz graduated from Perelman School of Medicine at the University of Pennsylvania in 1989.

What drugs does Dr. Miriam Pomeranz prescribe most?

In 2024 Medicare Part D data, Dr. Pomeranz's most prescribed drugs by claims were Triamcinolone Acetonide, Clobetasol Propionate and Ketoconazole.

Has Dr. Miriam Pomeranz received payments from drug or device companies?

CMS Open Payments shows $284 in general payments to Dr. Pomeranz from 4 companies from 2018 to 2025. The largest total came from Janssen Pharmaceuticals, Inc.

How long has Dr. Miriam Pomeranz been practicing?

Dr. Pomeranz graduated from medical school in 1989, 37 years ago.

Does Dr. Miriam Pomeranz do research?

Dmand AI links 69 publications to Dr. Pomeranz, published from 2011 to 2025.

Who does Dr. Miriam Pomeranz publish with?

Dr. Pomeranz's most frequent co-authors are Randie H. Kim, MD, PhD (6 shared papers), Kathryn Joyce Martires, MD (6 shared papers) and Alisa Nicole Femia, MD (4 shared papers).

Selling to dermatology practices?

See dermatologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)